Global Orthobiologics Market Size & Outlook, 2023-2030
Global orthobiologics market, 2018-2030 (US$M)
Related Markets
Global orthobiologics market highlights
- The global orthobiologics market generated a revenue of USD 6,367.4 million in 2023 and is expected to reach USD 9,237.3 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 5.5% by 2030.
- In terms of segment, viscosupplementation accounted for a revenue of USD 2,711.8 million in 2023.
- Stem Cell Therapy is the most lucrative product segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Denmark is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 6,367.4 million |
| Market revenue in 2030 | USD 9,237.3 million |
| Growth rate | 5.5% (CAGR from 2023 to 2030) |
| Largest segment | Viscosupplementation |
| Fastest growing segment | Stem Cell Therapy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Demineralized Bone Matrix(DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy |
Other key industry trends
- In terms of revenue, the North America accounted for 46.9% of the global orthobiologics market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Denmark is the fastest growing regional market and is projected to reach USD 52.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Orthobiologics Market Scope
Orthobiologics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global orthobiologics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthobiologics market will help companies and investors design strategic landscapes.
Viscosupplementation was the largest segment with a revenue share of 42.59% in 2023. Horizon Databook has segmented the Global orthobiologics market based on demineralized bone matrix(dbm), allograft, bone morphogenetic protein (bmp), viscosupplementation, synthetic bone substitutes, stem cell therapy covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Orthobiologics Product Outlook (Revenue, USD Million, 2018-2030)
- Demineralized Bone Matrix(DBM)
- Allograft
- Bone Morphogenetic Protein (BMP)
- Viscosupplementation
- Synthetic Bone Substitutes
- Stem Cell Therapy
- Global Orthobiologics Application Outlook (Revenue, USD Million, 2018-2030)
- Spinal Surgery
- Trauma Repair
- Reconstructive Surgery
- Global Orthobiologics End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Clinics
Reasons to subscribe to Global orthobiologics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global orthobiologics market databook
-
Our clientele includes a mix of orthobiologics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global orthobiologics market , including forecasts for subscribers. This global databook contains high-level insights into Global orthobiologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global orthobiologics market size, by regions, 2018-2030 (US$M)
Top 10 countries: Orthobiologics market size, 2023 (US$M)
Global orthobiologics market share, by product, 2023 & 2030 (%, US$M)
Orthobiologics market: Opportunity assessment by country
Global orthobiologics market, by region, 2023 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
